News and Inspirational Stories
New Report: ACS Cancer Facts & Figures 2024 report five-year relative survival rate for pancreatic cancer increased to 13%
FEATURED Articles
Discoveries
Cold Spring Harbor Laboratory (CSHL) is at the forefront of using organoid technology to study and treat cancer. Organoids are tiny 3D clusters of cells that are miniature versions of patients’ tumors.
The annual American Society of Clinical Oncology (ASCO) meeting brings together scientists from across the country who are studying every type of cancer to share the latest results from the […]
With a five-year survival rate of only 11%, pancreatic cancer patients need more effective therapies. A new form of immunotherapy is showing promise, as it shrank metastases and stopped progression […]
Neoadjuvant gemcitabine-based chemoradiotherapy prolonged OS compared with upfront surgery among patients with resectable and borderline resectable pancreatic cancer, according to phase 3 study results in Journal of Clinical Oncology.
Real Talk: Survivor, Patient & Family Stories
Dr. Elizabeth Legatt In 2019, retired obstetrician/gynecologist and thyroid cancer survivor Dr. Elizabeth Legatt, then 68, suddenly became prediabetic, and she didn’t know why. There had been no change in […]
Rachel Weiss Rachel Weiss’ father Ross was the quintessential “girl dad.” After raising two sons during his first marriage, he was overjoyed to welcome a baby girl with his second […]
Stefanie Wayco On February 2, 2017, Stefanie Wayco and her mom, Rita, discovered that the back pain Rita had been experiencing—which several doctors had attributed to a pulled muscle—was actually […]
Scot Davis Wanda Wolff was the glue holding her family together—a selfless mother who raised three sons on her own, an inspiring breast cancer survivor, an integral part of her […]
Early Detection
Newswise — A large international collaboration led by researchers from the Johns Hopkins Kimmel Cancer Center has identified promising new targets for pancreatic cancer treatment and early diagnosis after examining […]
Pancreatic cancer is tricky to identify. In the early stages, there might not be much—if any—indication something is even wrong, and that’s exactly why doctors often refer to it as […]
The incidental identification of pancreatic cysts has become more common with the increasing use of imaging modalities in clinical practice. Currently, an estimated 15% of Americans are believed to harbor […]
A test that spots pancreatic cancer from a single drop of blood could improve survival rates. The first blood test for early diagnosis of the hard-to-spot disease, it could be […]
Therapeutics
Preliminary analysis of data from an ongoing investigator-initiated, single-center Phase 1 study supported by BioNTech and Genentech and conducted at Memorial Sloan Kettering Cancer Center, New York, United States. Autogene […]
Research by Oregon State University has uncovered a potential new therapy for pancreatic cancer, whose survival rate is among the lowest of all malignancies.
When you’re facing a pancreatic cancer diagnosis, humor may be tough to come by. Instead, feelings of grief, sadness, depression and anxiety become so all-consuming that getting a chuckle from […]
Results from an ongoing phase 2b GRECO-2 clinical trial show that the novel drug GC4419 may be promising in treating patients with unresectable or borderline resectable locally advanced pancreatic cancer […]
Precision Medicine
A molecular test called PancreaSeq accurately classifies pancreatic cysts as potentially cancerous or benign, according to a large, multi-center study led by University of Pittsburgh School of Medicine and UPMC researchers.
Noxopharm Ltd (ASX:NOX) has delivered encouraging preclinical data from its novel ‘dual-cell’ therapy drug that attacks pancreatic cancer in a different and innovative way.
With a five-year survival rate of only 11%, pancreatic cancer patients need more effective therapies. A new form of immunotherapy is showing promise, as it shrank metastases and stopped progression […]
Researchers have managed to tame pancreatic cancer in a woman whose cancer was far advanced and after other forms of treatment had failed.
The Researchers
The annual American Society of Clinical Oncology (ASCO) meeting brings together scientists from across the country who are studying every type of cancer to share the latest results from the […]
Read our “Need to Know” summary and watch “Leading the Way: Equity, Accessibility and Diversity in Pancreatic Cancer Research” in its entirety on our YouTube channel.
Pingping Hou, PhD, of Rutgers Cancer Institute of New Jersey and Edwin Manuel, PhD, of the City of Hope, were announced at the American Association for Cancer Research (AACR) Annual […]